By Counterforce Health Team in Kuvan (sapropterin dihydrochloride) —

The Requirements Checklist to Get Kuvan (Sapropterin) Covered by Aetna CVS Health in Michigan

Answer Box: Getting Kuvan Covered by Aetna CVS Health in Michigan

Aetna CVS Health requires prior authorization for Kuvan (sapropterin) in PKU patients with phenylalanine levels ≥360 μmol/L (6 mg/dL) despite dietary management. You'll need confirmed PKU diagnosis, documented BH4 responsiveness (≥20% phenylalanine reduction), and specialist oversight. Submit via CVS Caremark portal or fax to 1-888-267-3277. If denied, Michigan residents have 127 days to file external appeals with DIFS. Start today: Gather recent phenylalanine labs and contact your metabolic specialist to initiate the PA process.

Table of Contents

  1. Who Should Use This Checklist
  2. Member & Plan Basics
  3. Clinical Criteria Requirements
  4. Coding & Documentation
  5. Submission Process
  6. Specialty Pharmacy Requirements
  7. After Submission: What to Expect
  8. Common Denial Reasons & Solutions
  9. Michigan Appeals Process
  10. Quick Reference Checklist

Who Should Use This Checklist

This guide is for Michigan residents with Aetna CVS Health insurance who need Kuvan (sapropterin dihydrochloride) for phenylketonuria (PKU). Use this checklist if you're:

  • A PKU patient whose phenylalanine levels remain elevated despite dietary restrictions
  • A parent or caregiver managing a child's PKU treatment
  • A healthcare provider submitting prior authorization requests
  • Someone who received a denial and needs to appeal

Expected outcome: Following this checklist improves your chances of approval by ensuring all required documentation is complete and properly submitted.

Member & Plan Basics

Coverage Verification

Before starting the PA process, confirm these basics:

Requirement Details Action Step
Active Coverage Verify current Aetna CVS Health enrollment Check member portal or call member services
Formulary Status Kuvan requires PA on most Aetna plans Review your plan's formulary or call CVS Caremark at 1-888-321-3124
Deductible Specialty tier may have higher out-of-pocket costs Check benefits summary for specialty drug coverage
CVS Specialty Required pharmacy for Kuvan fulfillment Enrollment needed post-approval
Note: Aetna CVS Health processes most specialty medications through CVS Specialty pharmacy exclusively.

Clinical Criteria Requirements

Aetna requires specific clinical evidence for Kuvan approval:

Primary Criteria

  1. Confirmed PKU Diagnosis
    • Enzyme assay results
    • Genetic testing confirming PAH deficiency
    • Newborn screening records
    • Phenylalanine levels ≥360 μmol/L (6 mg/dL) on dietary restriction alone
  2. Age Requirement
    • Patient must be ≥1 month old (FDA-approved age)
  3. BH4 Responsiveness
    • Documented trial showing ≥20% phenylalanine reduction from baseline
    • Trial must be completed within 90 days of PA submission
    • Current phenylalanine levels must remain >360 μmol/L despite dietary management
  4. Specialist Oversight
    • Treatment managed by metabolic specialist or geneticist
    • Ongoing dietary restriction plan in place
    • Regular monitoring protocol established

Exclusion Criteria

  • Concurrent use with pegvaliase (Palynziq) at stable maintenance dose
  • Certain tetrahydrobiopterin deficiencies (e.g., DHPR deficiency)
  • Use outside FDA-approved indications

Coding & Documentation

ICD-10 Diagnosis Codes

Use the correct diagnostic code for your submission:

  • E70.0 - Classical phenylketonuria (severe PAH deficiency)
  • E70.1 - Other hyperphenylalaninemias (mild to moderate PAH deficiency)

NDC Numbers

Kuvan requires product-specific NDC codes (verify with current formulary):

  • 100 mg tablets: Manufacturer-specific NDC
  • 100 mg powder for oral solution: Separate NDC
  • 500 mg powder for oral solution: Separate NDC
Important: Never use J-codes for Kuvan. It's exclusively a pharmacy benefit medication.

Documentation Packet Requirements

Your submission must include:

Provider Note Elements:

  • Current phenylalanine levels (≤90 days old)
  • PKU diagnosis confirmation
  • BH4 trial results with percentage reduction
  • Current dietary management plan
  • Weight for dosing calculations
  • Treatment goals and monitoring plan

Letter of Medical Necessity Components:

  • Patient demographics and insurance information
  • Detailed clinical history and current status
  • Prior treatment failures or inadequacy
  • Specific Aetna policy criteria addressed
  • Expected outcomes with Kuvan therapy
  • Provider attestation of medical necessity

Required Attachments:

  • Recent lab results
  • Genetic testing or enzyme assay results
  • BH4 trial documentation
  • Specialist consultation notes
  • Current dietary plan

Submission Process

Step-by-Step Submission

  1. Verify Current Forms
    • Download latest Aetna CVS Health PA form from provider portal
    • Confirm form version matches current requirements
  2. Choose Submission Method
    • Preferred: CVS Caremark provider portal
    • Alternative: Fax to 1-888-267-3277
    • Mail: Check current address on PA form
  3. Complete Required Fields
    • Patient information (name, DOB, member ID, group number)
    • Prescriber details (name, NPI, license, credentials)
    • Drug specifics (Kuvan brand/generic, dosage, frequency, duration)
    • Clinical justification
  4. Attach Supporting Documents
    • All items from documentation packet checklist
    • Ensure all documents are legible and dated

Common Submission Errors to Avoid

  • Incomplete patient demographics
  • Missing or outdated phenylalanine levels
  • Unsigned provider attestation
  • Wrong NDC codes
  • Missing BH4 trial documentation

Specialty Pharmacy Requirements

CVS Specialty Enrollment

Once approved, Kuvan must be filled through CVS Specialty:

  1. Patient Enrollment
    • Complete CVS Specialty enrollment forms
    • Provide insurance and shipping information
    • Set up preferred delivery schedule
  2. Provider Requirements
    • Send prescription to CVS Specialty
    • Provide any additional clinical documentation
    • Coordinate ongoing monitoring
  3. Shipment Coordination
    • Verify delivery address and timing
    • Arrange for refrigerated storage if needed
    • Confirm receipt and proper handling
Tip: Start CVS Specialty enrollment immediately after PA approval to avoid treatment delays.

After Submission: What to Expect

Timeline and Status Tracking

Stage Timeline Action
Initial Review 30-45 days standard Record confirmation number
Expedited Review ≤72 hours (urgent cases) Requires physician urgency letter
Status Checks Weekly after 2 weeks Call CVS Caremark or check portal
Decision Notification Written notice to provider and patient Save all correspondence

What to Record

  • Submission confirmation number
  • Date of submission
  • Method used (portal/fax)
  • Representative names if calling
  • All reference numbers
  • Decision dates and outcomes

Common Denial Reasons & Solutions

Denial Reason Solution Strategy
"Not medically necessary" Submit enhanced clinical documentation with specific policy criteria addressed
"Non-formulary" Request formulary exception with comparative effectiveness data
"Step therapy not completed" Document dietary therapy trial and inadequate response
"Insufficient documentation" Resubmit with complete packet including all required elements
"Experimental/investigational" Provide FDA labeling and established clinical guidelines

Five Critical Pitfalls to Avoid

  1. Missing BH4 Trial Data - Always include documented responsiveness testing
  2. Outdated Lab Values - Use phenylalanine levels within 90 days
  3. Incomplete Provider Information - Verify all NPI and license numbers
  4. Wrong Billing Pathway - Never attempt medical benefit billing with J-codes
  5. Generic PA Forms - Use current Aetna CVS Health-specific forms

Michigan Appeals Process

Internal Appeals with Aetna

If your initial request is denied:

  1. File Internal Appeal
    • Deadline: 180 days from denial notice
    • Submit via provider portal or fax
    • Include denial letter and additional supporting evidence
  2. Peer-to-Peer Review
    • Request physician-to-physician discussion
    • Prepare clinical talking points
    • Document conversation outcomes

Michigan External Review

If internal appeals fail, Michigan residents have strong external review rights:

Filing Deadline: 127 days from final Aetna denial

How to File:

Required Documentation:

  • Copy of final Aetna denial
  • Detailed appeal rationale
  • Supporting medical records
  • DIFS Treating Provider Certification (if applicable)

Timeline:

  • Standard review: 60 days maximum
  • Expedited review: 72 hours (with physician urgency letter)

Contact: Michigan DIFS at 877-999-6442 (Monday-Friday, 8 a.m. to 5 p.m.)

Important: Michigan's external review decisions are binding on insurers. If approved, Aetna must provide coverage as directed.

Quick Reference Checklist

Before You Start

  • Verify active Aetna CVS Health coverage
  • Confirm current phenylalanine levels (≤90 days)
  • Gather PKU diagnosis documentation
  • Complete BH4 responsiveness testing
  • Identify metabolic specialist for oversight

Clinical Requirements

  • PKU diagnosis confirmed (E70.0 or E70.1)
  • Patient ≥1 month old
  • Phenylalanine ≥360 μmol/L despite diet
  • BH4 trial showing ≥20% reduction
  • Specialist management in place

Documentation Package

  • Completed Aetna CVS Health PA form
  • Letter of medical necessity
  • Recent phenylalanine levels
  • PKU diagnosis confirmation
  • BH4 trial results
  • Specialist consultation notes
  • Current dietary management plan

Submission

  • Correct NDC codes used
  • All required fields completed
  • Provider signature and date
  • Confirmation number recorded
  • Follow-up schedule established

From Our Advocates: We've seen PKU families succeed with Aetna appeals by focusing on the specific policy language around BH4 responsiveness. One family's initial denial was overturned after their specialist provided detailed trial data showing a 35% phenylalanine reduction, directly addressing Aetna's ≥20% threshold requirement. The key was mapping every piece of evidence to the exact policy criteria.

Getting Kuvan covered by Aetna CVS Health requires careful attention to clinical criteria and documentation requirements. Counterforce Health helps patients and providers navigate complex prior authorization processes by analyzing denial letters and crafting targeted appeals that address specific payer requirements. Our platform identifies the exact reasons for denials and provides evidence-backed responses that align with each plan's own rules.

For Michigan residents facing Aetna denials, the state's robust external review process through DIFS provides an important safety net. With 127 days to file and binding decisions, the external review can be a powerful tool when internal appeals fail. Remember to gather comprehensive documentation, work closely with your metabolic specialist, and don't hesitate to use Counterforce Health's resources to strengthen your appeal.

Sources & Further Reading

Disclaimer: This guide is for informational purposes only and does not constitute medical or legal advice. Insurance coverage decisions depend on individual circumstances, plan terms, and clinical factors. Always consult with your healthcare provider and insurance plan for specific guidance. For additional support with Michigan health insurance appeals, contact Michigan DIFS at 877-999-6442.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.